-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Clearside Biomedical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
- Clearside Biomedical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.69M, a 17% increase year-over-year.
- Clearside Biomedical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$31.9M, a 14.6% increase year-over-year.
- Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$32.5M, a 1.4% increase from 2022.
- Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$32.9M, a 8863% decline from 2021.
- Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $376K.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)